Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Buy Us a Coffee
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2021-22916
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
In Brave Desktop between versions 1.17 and 1.26.60, when adblocking is enabled and a proxy browser extension is installed, the CNAME adblocking feature issues DNS requests that used the system DNS settings instead of the extension's proxy settings, resulting in possible information disclosure.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
信息暴露
Source: NVD (National Vulnerability Database)
Vulnerability Title
Brave 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Brave是美国Brave公司的一个快速，私密和安全的Web浏览器。 Brave Desktop 1.17 - 1.26.60版本存在安全漏洞，该漏洞可能导致信息泄露。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-https://github.com/brave/brave-core Fixed in 1.26.60 -
II. Public POCs for CVE-2021-22916
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2021-22916
Please Login to view more intelligence information
IV. Related Vulnerabilities
Same product: https://github.com/brave/brave-core
Same vendor: n/a
Same weakness: CWE-200
V. Comments for CVE-2021-22916

No comments yet

Leave a comment